ENHANCED ANTI-TUMOR ACTIVITY OF CD19.CAR-NK CELLS BY INCORPORATING IL-27 AFB Biggi; RN Silvestre; JTC Azevedo; MC Tirapelle; KCR Malmegrim; ML Figueiredo; DT Covas; V Picanço-Castro;

PROMOTER CHOICE: THE IDEAL PROMOTER TO DRIVE CHIMERIC ANTIGEN RECEPTOR (CAR) EXPRESSION IN NK CELLS RN Silvestre; J Eitler; JTC Azevedo; KCR Malmegrim; K Swiech; DT Covas; T Tonn; V Picanço-Castro;

NK-SPECIFIC CAR DESIGN IMPROVES NK CYTOTOXICITY AGAINST TUMOR CELLS JTC Azevedo; RN Silvestre; DT Covas; V Picanço-Castro;